A novel drug that produces a temporary coating in the small intestine could be a new strategy for weight loss—and an alternative to surgeries and GLP-1 drugs.

Currently, 13 states cover GLP-1 medications for obesity treatment, according to KFF ... said Rachel Sachs, law professor at Washington University. That's because the medications are also gaining ...

Obesity is associated with longer operative ... Childers, MD, PhD, Department of Surgery, University of Washington, Seattle. It was published online in the Journal of the American College of ...

Washington State Office of the Attorney General, AbilTo, Kansas City Area Life Sciences Institute, Luxembourg National Research Fund, National Science Foundation, University of California Los ...

Currently, 13 states cover GLP-1 medications for obesity treatment ... law professor at Washington University. That's because the medications are also gaining approval to treat other conditions ...

"When something [like this award] drops in completely unexpected, that's nice, that's wonderful," Holst, a professor of ...